Moderna Requests Approval for its Children’s VaccineBy Radiant Health
Published: May 15, 2022
Moderna has asked the FDA to approve its COVID-19 vaccine specifically made for children aged 6 to 11. The drug has already been authorized for this age group in Australia and Canada. Pfizer’s vaccine for the same age group has been available for months, and it hasn’t done well. Only about 29% of children between the ages of 5 and 11 have received two doses. The company says its recent data suggests that the vaccine is 88% effective against severe disease.
Like what you're reading? Sign up for our free newsletter and never miss a post! Plus get a FREE digital version of our Issue No.10 with sign up.
- Babies and Toddlers Get COVID-19 Shots - June 27, 2022
- FDA Bans Juul’s E-Cigarettes and Cartridges - June 27, 2022
- Polio Virus Found in London Sewage - June 27, 2022
- 200 Million Americans Are Drinking Contaminated Water - June 19, 2022
- Young Kids Can Finally Get Vaccinated Against COVID-19 - June 19, 2022
- New Regulations for Baby Sleep Products - June 19, 2022
- FDA Approves First Drug for Alopecia Hair Loss - June 19, 2022
- Personal Use of Hard Drugs Decriminalized in British Columbia - June 6, 2022
- Woman Receives a Brand New Type of Ear Transplant - June 6, 2022
- Children 6 Months and Older are Eligible for Pfizer’s COVID Vaccine - June 6, 2022